Table 9 Agreement between PET/CT and BMB in HD lymphoma cases
From: PET/CT and bone marrow biopsy (BMB) in evaluating bone marrow in lymphoma
| Â | Â | BMB | Total | ||
|---|---|---|---|---|---|
Negative | Positive | Â | |||
PET/CT | Negative | Count | 69 | 1 | 70 |
% of total | 78.4% | 1.1% | 79.5% | ||
Positive | Count | 13 | 5 | 18 | |
% of total | 14.8% | 5.7% | 20.5% | ||
Total | Â | Count | 82 | 6 | 88 |
% of total | 93.2% | 6.8% | 100.0% | ||